Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201210085 Principal Investigator: Ma, Cynthia
Title: A phase III randomized, double blind, placebo controlled study of BKM120 with fulvestrant, in postmenopausal women with hormone receptor-positive HER2-negative AI treated, locally advanced or metastatic breast cancer who progressed on or after mTOR inhibitor based treatment
Phase: III Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this trial is to see the safety and efficacy of fulvestrant with an investigational drug (BKM120) in patients with hormone receptor positive metastatic breast cancer that have recently progressed on a mTOR inhibitor (everlimous).
 
More Information:
ClincalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)